Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

European Journal of Immunology

Volumn 29, Issue 6, 1999, Pages 2026-2036

  Ball, Tanja ^a   Sperr, Wolfgang R ^a   Valent, Peter ^a   Lidholm, Jonas ^b   Spitzauer, Susanne ^c   Ebner, Christof ^a   Kraft, Dietrich ^a   Valenta, Rudolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b PFIZER INC   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergy; Antibody; Epitope; Immunotherapy; Vaccine

Indexed keywords

ALLERGEN; EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; POLLEN ANTIGEN;

ALLERGY; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; GRASS POLLEN; HUMAN; HUMORAL IMMUNITY; IMMUNOTHERAPY; PRIORITY JOURNAL;

EID: 0033065121     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2     Document Type: Article

References (54)

1. Kay, A. B., (Ed.) Allergy and Allergic diseases. Blackwell Science, Oxford 1997.
2. Casolaro, V., Georas, S. N., Song, Z. and Ono, S. J., Biology and genetics of atopic disease. Curr. Opin Immunol. 1996. 8: 796-803.
3. Valenta, R., Maurer, D., Steiner, R., Seiberler, S., Sperr, W. R., Valent, P., Spitzauer, S., Kapiotis, S., Smolen, J. and Stingl, G., Immunoglobulin E response to human proteins in atopic patients. J. Invest. Dermatol. 1996. 107: 203-208.
4. Natter, S., Seiberler, S., Hufnagl, P., Binder, B. R., Hirschl, A. M., Ring, J., Abeck, D., Schmidt, T., Valent, P. and Valenta, R., Isolation of cDNA clones coding for IgE autoantigens with serum IgE form atopic dermatitis patients. FASEB J. 12: 1559-1569.
5. Valenta, R., Natter, S., Seiberler, S., Wichlas, S., Maurer, D., Hess, M., Pavelka, M., Grote, M., Ferreira, F., Szepfalusi, Z., Valent, P. and Stingl, G., Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J. Invest. Dermatol. 1998. 111: 1178-1183.
6. Bousquet, J., Lockey, R., Malling, H. J. and the WHO panel members, Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper. J. Allergy Clin. Immunol. 1998. 102: 558-562.
7. Noon, L., Prophylactic inoculation against hayfever. Lancet 1911. 1: 1572-1573.
8. Durham, S. R. and Till, S. J., Immunological changes associated with allergen immunotherapy. J. Allergy Clin. Immunol. 1998. 102: 157-164.
9. Cooke, R., Barnard, J., Hebald, S. and Stull, A., Serological evidence on immunity with co-existing sensitization in a type of human allergy, hay fever. J. Exp. Med. 1935. 62: 733-750.
10. Loveless, M. H., Immunological studies of pollinosis: I. The presence of two antibodies related to the same pollen antigen in the serum of treated hay fever patients. J. Immunol. 1940. 38: 25-50.
11. Loveless, M. H., Immunological studies on pollinosis. IV. The relationship between thermostable antibody in the circulation and clinical immunity. J. Immunol. 1943. 47: 165-180.
12. Lichtenstein, L. M., Holtzman, N. A. and Burnett, L. S., A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J. Immunol. 1968. 101: 317-324.
13. Sobotka, A. K., Valentine, M. D., Ishizaka, K. and Lichtenstein, L. M., Measurement of IgG blocking antibodies: development and application of a radioimmunoassay. J. Immunol. 1996. 117: 84-90.
14. Adkinson, N. F., Sobotka, A. K. and Lichtenstein, L. M., Evaluation of the quantity and affinity of human IgG "blocking" antibodies. J. Immunol. 1979. 122: 965-972.
15. Gleich, G. J., Zimmermann, E. M., Gleich, M. C. and Yunginger, J. W., Measurement of IgG blocking antibodies by interference in the radioallergosorbent test. J. Immunol. 1981. 126: 575-579.
16. Aalberse, R. C., Gaag, R. and Leeuwen, J., Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 1983. 130: 722-726.
17. Gleich, G. J., Zimmermann, E. M., Henderson, L. L. and Yunginger, J. W., Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J. Allergy Clin. Immunol. 1982. 70: 261-271.
18. Urbanek, R., Kemeny, D. M. and Richards, D., Subclass of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clin. Allergy 1986. 16: 317-322.
19. Birkner, T., Rumpold, H., Jarolim, E., Ebner, H., Breitenbach, M., Skvaril, T., Scheiner, O. and Kraft, D., Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 1990. 41: 418-426.
20. Djurup, R. and Osterballe, O., IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels in immunotherapy. Allergy 1984. 39: 433-441.
21. Creticos, P. S., Adkinson, N. F., Jr., Kagey-Sobotka, A., Proud, D., Meier, H. L., Naclerio, R. M., Lichtenstein, L. M. and Norman, P. S., Nasal challenge with ragweed in hay fever patients: Effect of immunotherapy. J. Clin. Invest. 1985. 76: 2247-2253.
22. Otsuka, H., Mezawa, A., Ohnishi, M., Okubo, K., Sehi, H. and Okuda, M., Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allergy 1991. 21: 115-120.
23. Durham, S. R., Ying, S., Varney, V. A., Jacobson, M. R., Sudderick, R. M., Mackay, I. S., Kay, A. B. and Hamid, Q. A., Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J. Allergy Clin. Immunol. 1996. 97: 1356-65.
24. Furin, M. M., Norman, P. S., Creticos, P. S., Proud, D., Kagey-Sobotka, A., Lichtenstein, L. M. and Naclerio, R. M., Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity. J. Allergy Clin. Immunol. 1991. 88: 27-32.
25. Rak, S., Rowhagen, O. and Venge, P., The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients. J. Allergy Clin. Immunol. 1988. 82: 470-480.
26. Rocklin, R. E., Sheffer, A., Greineder, D. K. and Melmon, K. L., Generation of antigen-specific supressor cells during allergy desensitization. N. Engl. J. Med. 1980. 302: 1213-1219.
27. + T cells from allergic individuals. J. Exp. Med. 1993. 178: 2123-2130.
28. Secrist, H., DeKruyff, R. H. and Umetsu, D. T., Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 1995. 181: 1081-1089.
29. Jutel, M., Pichler, W. J., Skrbic, D., Urwyler, A., Dahinden, C. and Müller, U. R., Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 1995. 154: 4187-4194.
30. O'Brien, R. M., Byron, K. A., Varigos, G. A. and Thomas, W. R., House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-γ and IL-4 expression by circulation T lymphocytes. Clin. Exp. Allergy 1997. 27: 46-51.
31. Vrtala, S., Ball, T., Spitzauer, S., Pandjaitan, B., Suphioglu, C., Knox, B., Sperr, W. R., Valent, P., Kran, D. and Valenta, R., Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J. Immunol. 1998. 160: 6137-6144.
32. Laffer, S., Valenta, R., Vrtala, S., Susani, M., van Ree, R., Kraft, D., Scheiner, O. and Ducnene, M., Complementary DNA cloning of the major allergen Phl p 1 from timothy grass (Phleum pratense); recombinant Phl p 1 inhibits IgE binding to group I allergens from eight different grass species. J. Allergy Clin. Immunol. 1994. 94: 689-698.
33. Fischer, S., Grote, M., Fahlbusch, B., Müller, W. D., Kraft, D. and Valenta, R., Characterization of Phl p 4, a major timothy grass pollen allergen. J. Allergy Clin. Immunol. 1996. 98: 189-198.
34. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kölsch, E., Podlaski, F. J., Gately, M. K. and Rüde, E., Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 1995. 25: 823-829.
35. Kolbe, L., Heusser, C. and Kölsch, E., Antigen dose dependent regulation of B epsilon-memory cell expression. Int. Arch. Allergy Appl. Immunol. 1991. 95: 202-206.
36. Akdis, C. A., Blesken, T., Wymann, D., Akdis, M. and Blaser, K., Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Eur. J. Immunol. 1998. 28: 914-925.
37. Ebner, C., Siemann, U., Bohle, B., Wilhelm, M., Wiedermann, U., Schenk, S., Klotz, F., Ebner, H., Kraft, D. and Scheiner, O., Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin. Exp. Allergy 1997. 27: 1007-1015.
38. Valenta, R. and Kraft, D., Recombinant allergens for diagnosis and therapy of allergic diseases. Curr. Opin. Immunol. 1995. 7: 751-756.
39. Valenta, R., Vrtala, S., Laffer, S., Spitzauer, S. and Kraft, D., Recombinant allergens. Allergy 1998. 53: 552-561.
40. Valenta, R., Almo, S., Ball, T., Dolecek, C., Steinberger, P., Laffer, S., Eibensteiner, P., Flicker, S., Vrtala, S., Spitzauer, S., Valent, P., Denepoux, S., Kraft, D., Banchereau, J. and Lebecque, S., The immunoglobulin E-allergen interaction: A target for therapy of type I allergic diseases. Int. Arch. Allergy Immunol. 1998. 116: 167-176.
41. Ball, T., Vrtala, S., Sperr, W. R., Valent, P., Susani, M., Kraft, D. and Valenta, R., Isolation of an immunodominant IgE-hapten from an epitope expression cDNA library; dissection of the allergic effector reaction. J. Biol. Chem. 1994. 269: 28323-28328.
42. Smith, A. M. and Chapman, M. D., Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2. Mol. Immunol. 1996. 33: 399-405.
43. Ferreira, F., Hirtenlehner, K., Jilek, A., Godnik-Cvar, J., Breiteneder, H., Grimm, R., Hoffmann-Sommergruber, K., Scheiner, O., Kraft, D., Breitenbach, M., Rheinberger, H. J. and Ebner, C., Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen, Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J. Exp. Med. 1996. 183: 599-609.
44. Vrtala, S., Hirtenlehner, K., Vangelista, L., Pastore, A., Eichler, H. G., Sperr, W. R., Valent, P., Ebner, C., Kraft, D. and Valenta, R., Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments. Candidates for a novel form of specific immunotherapy. J. Clin. Invest. 1997. 99: 1673-1681.
45. Takai, T., Yokota, T., Yasue, M., Nishiyama, C., Yuuki, T., Mori, A., Okudaira, H. and Okumura, Y., Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat. Biotechnol. 1997. 15: 754-758.
46. Ferreira, F., Ebner, C., Kramer, B., Casari, G., Briza, P., Kungl, A. J., Grimm, R., Jahn-Schmid, B., Breiteneder, H., Kraft, D., Breitenbach, M., Rheinberger, H. J. and Scheiner, O., Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J. 1998. 12: 231-242.
47. Vrtala, S., Susani, M., Sperr, W. R., Valent, P., Laffer, S., Dolecek, C., Kraft, D. and Valenta, R., Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5). J. Allergy Clin. Immunol. 1996. 97: 781-787.
48. Niederberger, V., Hayek, B., Vrtala, S., Laffer, S., Twardosz, A., Vangelista, L., Sperr, W. R., Valent, P., Rumpold, H., Kraft, D., Ehrenberger, K., Valenta, R. and Spitzauer, S., Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a crossreactive two EF-hand timothy grass pollen allergen, Phl p 7. FASEB J. 1999, in press.
49. Valenta, R., Ball, T., Vrtala, S., Duchêne, M., Kraft, D. and Scheiner, O., cDNA cloning and expression of timothy grass (Pleum pratense) pollen profilin in Escherichia coli: comparison with birch pollen profilin. Biochem. Biophys. Res. Commun. 1994. 199: 106-118.
50. Vrtala, S., Wiedemann, P., Mittermann, I., Eichler, H. G., Sperr, W. R., Valent, P., Kraft, D. and Valenta, R., High-level expression in Escherichia coli and purification of recombinant plant profilins: Comparison of IgE-binding capacity and allergenic activity. Biochem. Biophys. Res. Commun. 1996. 226: 42-50.
51. van-Ree, R., Hoffmann, D. R., van-Dijk, W., Brodard, V., Mahieu, K., Koeleman, C. A., Grande, M., van-Leeuwen, W. A. and Aalberse, R. C., Lol p XI, a new major grass pollen allergen, is a member of a family of soybean trypsin inhibitor-related proteins. J. Allergy Clin. Immunol. 1995. 95: 970-978.
52. Sanger, F., Nicklen, S. and Coulson, A. R., DNA sequencing with chain-termination inhibitors. Proc. Natl. Acad. Sci. USA 1977. 74: 5463-5467.
53. Sambrook, J., Fritsch, E. F. and Maniatis, T., Molecular cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1989.
54. Valent, P., Besemer, J., Muhm, M., Majdic, O., Lechner, K. and Bettelheim, P., Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc. Natl. Acad. Sci. USA 1989. 86: 5542-5547.